Literature DB >> 11186866

Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease.

N Stuebiger, I Koetter, M Zierhut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186866      PMCID： PMC1723361          DOI： 10.1136/bjo.84.12.1432g

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

Review 1.  Behçet's disease: from Hippocrates to the third millennium.

Authors:  D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease.

Authors:  Hadise Kavandi; Alireza Khabbazi; Sousan Kolahi; Mehrzad Hajialilo; Farid Karkon Shayan; Mohammad Oliaei
Journal:  Clin Rheumatol       Date:  2016-05-27       Impact factor: 2.980

3.  Neovascularization of the optic disc in Behçet's disease.

Authors:  Ilknur Tugal-Tutkun; Sumru Onal; Rana Altan-Yaycioglu; Nur Kir; Meri Urgancioglu
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

Review 4.  Current and future treatments for Behçet's uveitis: road to remission.

Authors:  Marina Mesquida; Blanca Molins; Victor Llorenç; María Victoria Hernández; Gerard Espinosa; Andrew D Dick; Alfredo Adán
Journal:  Int Ophthalmol       Date:  2013-06-01       Impact factor: 2.031

Review 5.  Ischemic retinal vasculitis and its management.

Authors:  Lazha Talat; Sue Lightman; Oren Tomkins-Netzer
Journal:  J Ophthalmol       Date:  2014-04-15       Impact factor: 1.909
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.